Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H6 |
Molecular Weight | 78.1118 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C1=CC=CC=C1
InChI
InChIKey=UHOVQNZJYSORNB-UHFFFAOYSA-N
InChI=1S/C6H6/c1-2-4-6-5-3-1/h1-6H
DescriptionSources: http://pubs.acs.org/doi/pdf/10.1021/ja01273a045
Sources: http://pubs.acs.org/doi/pdf/10.1021/ja01273a045
Phenyl sodium is organometallic compound. It is used to carry exchange reactions to produce phenylmalonic acid.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Induction of apoptosis by remoxipride metabolites in HL60 and CD34+/CD19- human bone marrow progenitor cells: potential relevance to remoxipride-induced aplastic anemia. | 1999 Aug 1 |
|
Absorption, metabolism, and disposition of 1,3-diphenyl-1-triazene in rats and mice after oral, i.v., and dermal administration. | 1999 Dec |
|
Metabolism of benzene in human liver microsomes: individual variations in relation to CYP2E1 expression. | 1999 Feb |
|
Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome. | 1999 May |
|
Benzene in blood as a biomarker of low level occupational exposure. | 1999 Sep 1 |
|
Biomarkers of dose and susceptibility in cyclists exposed to monoaromatic hydrocarbons. | 1999 Sep 5 |
|
Bioconversion of vitamin E acetate in human skin. | 2001 |
|
Caffeic acid phenethyl ester (CAPE): synthesis and X-ray crystallographic analysis. | 2001 Feb |
|
Absorption spectroscopic study of EDA complexes of. | 2001 Feb |
|
Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography. | 2001 Feb |
|
Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: studies with DFP, a cyclooxygenase-2 inhibitor. | 2001 Feb |
|
Protective effects of SM-20302, an orally active GPIIb/IIIa antagonist, in an ADP/epinephrine-induced guinea pig model of transient cerebral ischemia. | 2001 Feb 1 |
|
Adsorbate-substrate vibrational modes of benzene on Ag(110) resolved with scanning tunneling spectroscopy. | 2001 Feb 5 |
|
Enhancement, relaxation, and reversal of the stereoselectivity for phosphotriesterase by rational evolution of active site residues. | 2001 Feb 6 |
|
Characterization of emissions during the heating of tyre contaminated scrap. | 2001 Feb-Mar |
|
An experimental and numerical study of the thermal oxidation of chlorobenzene. | 2001 Feb-Mar |
|
The disposition and metabolism of durene (1,2,4,5-tetramethylbenzene) in rats. | 2001 Jan |
|
[[Physical chemical, pharmacological and toxicologic properties of fomocaine metabolites] ]. | 2001 Jan |
|
Desulfosporosinus meridiei sp. nov., a spore-forming sulfate-reducing bacterium isolated from gasolene-contaminated groundwater. | 2001 Jan |
|
Electric field-induced mobilisation of multiphase solution systems based on the nitration of benzene in a micro reactor. | 2001 Jan |
|
N-nitrosoanilines: a new class of caspase-3 inhibitors. | 2001 Jan |
|
Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice. | 2001 Jan |
|
Molecular oxygen spin-lattice relaxation in solutions measured by proton magnetic relaxation dispersion. | 2001 Jan |
|
Quantification of derivatives of bisphenol A diglycidyl ether (BADGE) and novolac glycidyl ether (NOGE) migrated from can coatings into tuna by HPLC/fluorescence and MS detection. | 2001 Jan 2 |
|
Catalytic hydrodechlorination of tetrachloroethylene over red mud. | 2001 Jan 29 |
|
Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization. | 2001 Mar |
|
In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. | 2001 Mar |
|
Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition. | 2001 Mar |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C44351
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
||
|
IARC | Benzene | ||
|
NCI_THESAURUS |
C1915
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
200-753-7
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
34
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
D001554
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
C302
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
1601146
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
SUB13010MIG
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
m2338
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | Merck Index | ||
|
67315
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
DTXSID3039242
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
71-43-2
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
J64922108F
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
16716
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
1311295
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | RxNorm | ||
|
J64922108F
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
100000077173
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
241
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY | |||
|
BENZENE
Created by
admin on Fri Dec 15 15:00:54 GMT 2023 , Edited by admin on Fri Dec 15 15:00:54 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)